Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1287627 Target Snapshot

Cytochrome b-245 heavy chain · SINGLE PROTEIN · Homo sapiens

144Compounds
50Assays
1Approved Drugs
207.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P04839. Use UniProt P04839 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P04839 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome b-245 heavy chain as ChEMBL target CHEMBL1287627, mapped to UniProt P04839. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome b-245 heavy chain
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL1287627
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P04839
NADPH oxidase 2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome b-245 heavy chain is the right protein anchor across sources, using UniProt P04839 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNADPH oxidase 2
UniProt AccessionP04839
Component TypeProtein
Sequence Length570 aa

NADPH oxidase 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome b-245 heavy chain, mapped to UniProt P04839. ChEMBL maps the protein component as NADPH oxidase 2. Sequence length is 570 aa.

Mapped IDP04839
Review nameCytochrome b-245 heavy chain
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
2
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC50184.0
KI22.0
EC501.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3347550 7.52 IC50 30.0 Preclinical
CHEMBL3347551 7.52 IC50 30.0 Preclinical
CHEMBL3733336 7.52 IC50 30.0 Preclinical
CHEMBL5413611 7.27 Ki 54.0 Preclinical
CHEMBL397686 7.0 IC50 100.0 Preclinical
CHEMBL4210329 7.0 IC50 100.0 Preclinical
CHEMBL5413611 6.83 IC50 149.0 Preclinical
CHEMBL51085 6.52 IC50 300.0 Clinical
CHEMBL1927146 6.44 Ki 365.0 Preclinical
CHEMBL1927160 6.36 Ki 433.0 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
38
5.5
16
6.0
2
6.5
4
7.0
4
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

50
Total Assays
116
Tested Compounds
3
Assay Types
Binding — 48 assays, 116 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 34 38 5.0
single protein format 12 34 5.8
assay format 1 5 4.9
cell-free format 1 39
Functional — 1 assays, 17 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 17 6.0
Unassigned — 1 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 2 5.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine